iSpecimen Inc. (NASDAQ:ISPC) Sees Significant Increase in Short Interest

iSpecimen Inc. (NASDAQ:ISPC) was the recipient of a large increase in short interest in the month of October. As of October 30th, there was short interest totaling 305,211 shares, an increase of 92.3% from the October 15th total of 158,754 shares. Based on an average trading volume of 412,744 shares, the short-interest ratio is currently 0.7 days. Currently, 13.8% of the shares of the company are sold short.

iSpecimen Stock Down 5.4%

Shares of iSpecimen stock traded down $0.04 on Friday, reaching $0.66. 113,271 shares of the stock were exchanged, compared to its average volume of 305,883. iSpecimen has a twelve month low of $0.63 and a twelve month high of $27.44. The firm has a market capitalization of $1.66 million, a price-to-earnings ratio of -0.01 and a beta of 1.54. The business has a 50 day moving average price of $1.07 and a two-hundred day moving average price of $4.25.

iSpecimen (NASDAQ:ISPC) last issued its earnings results on Friday, August 14th. The company reported ($0.98) EPS for the quarter. iSpecimen had a negative net margin of 2,445.40% and a negative return on equity of 524.39%. The firm had revenue of $0.15 million during the quarter.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded iSpecimen from a “sell (e)” rating to a “sell (e+)” rating in a research note on Thursday, October 29th. One research analyst has rated the stock with a Sell rating. According to MarketBeat, the company presently has an average rating of “Sell”.

About iSpecimen

iSpecimen, Inc. (NASDAQ: ISPC) operates a technology-enabled marketplace that connects life sciences researchers with sources of human biospecimens. Its platform is designed to help pharmaceutical, biotechnology, diagnostic and academic organizations identify, search for and procure biological samples and associated clinical data for research and development. The company’s offerings support access to a range of specimen types, including blood, tissue and other human-derived samples obtained through healthcare providers, laboratories, biobanks and research institutions. iSpecimen also facilitates custom collection programs and related sourcing services intended to help customers obtain specimens that meet specific scientific, demographic and clinical requirements.